Physician

Infectious Disease

Dr. Jiejian Lin, MD


Doctor Jiejian Lin, MD practices Infectious Disease. He studied medicine at Baylor College of Medicine. Jiejian accepts Medicare.



Schools


Doctors Specialties


Accepted Insurances


Education


Hospital


Drug Facts


NPI NUMBER   1679533533
NPPES Provider LastName   LIN
NPPES Provider FirstName   JIEJIAN
NPPES Provider ZIPCode   770028233
NPPES Provider State   TX
Specialty Description   Infectious Disease
Total Claim Count   748.0
Distinct Opioid Count   0.0
Opioid Claim Count   0.0
Percent Opioid Claims   0.0

Helpful Reviews


Give Anonymous Review


Medicare Facts


National Provider Identifier [NPI] 1679533533
Last Name Of The Provider LIN
First Name Of The Provider JIEJIAN
View All

Similar Doctors


Dr. Pornthep Wattanamano, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Javier A. Adachi, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Hanna J. Abu-Nassar, MD
Dr. Roy F. Chemaly, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Elizabeth Y. Chiao, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Frederick J. Buckwold, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Rabih O. Darouiche, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Roshni G. Daver, MD
This Doctor is OpenDoctor Recommended.
Dr. Todd M. Price, MD
Dr. Ashley Drews, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Rodrigo Hasbun, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Didier F. Piot, MD
Dr. Vicente F. Corrales Medina, MD
Dr. Hana M. El Sahly, MD
This Doctor is OpenDoctor Recommended.
Dr. Dimitrios P. Kontoyiannis, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Muhammad F. Khan, MD
This Doctor is OpenDoctor Recommended.
Dr. Karlene C. Reid, MD
This Doctor is OpenDoctor Recommended.


Doctor Directory | TOS | twitter | FB | Angel | blog